Live Breaking News & Updates on Special Access Programme|Page 7
Stay updated with breaking news from Special access programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investorideas.com - Investor Ideas Potcasts #507, Cannabis News and Stocks on the Move: (CSE: PULL) (OTCQB: DRVD) (CSE: HOLL) (CSE: STEM) investorideas.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorideas.com Daily Mail and Mail on Sunday newspapers.
First-of-its-kind policy amendment will allow legal access to evidence-based treatments to those in need before formal drug approval VANCOUVER, BC, Dec. 11, 2020 /CNW/ - . ( Numinus or the Company ) (TSXV:NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, commends Health Canada s leadership for its intention to revise the Special Access Programme (SAP) to permit access to MDMA and psilocybin-assisted psychotherapy. The intended SAP revision, announced today, will positively affect the lives of the many Canadians experiencing mental health conditions who have not responded to existing therapies. Numinus leadership has worked to inform Health Canada and to advocate for an evidence-based revision of the SAP regulations. Health Canada s announcement recognizes a growing body of research including a range of clinic ....